Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Molotkov

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioinformatics Advances|September 25, 2023
Detecting biased validation of predictive models in the positive-unlabeled setting: disease gene prioritization case studyIvan Molotkov, Mykyta Artomov
Disease Models & Mechanisms|December 16, 2024
Making sense of missense: challenges and opportunities in variant pathogenicity predictionIvan Molotkov, Elaine R Mardis, Mykyta Artomov
Nature Communications|December 13, 2025
Cost-effective non-additive GWAS across 2329 diseases in 500,349 individualsIvan Molotkov, Mitja Kurki, , et al.
JID Innovations : Skin Science From Molecules to Population Health|November 30, 2023
Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and VitiligoSarem Rashid, Ivan Molotkov, Nikolai Klebanov, et al.
Nature Communications|June 20, 2026
PGS Browser: a public platform for personalized polygenic score analysis and interpretationNikita Kolosov, Mary P Reeve, Pietro Della Briotta Parolo, et al.
Nature Communications|July 23, 2024
Complex trait susceptibilities and population diversity in a sample of 4,145 RussiansDmitrii Usoltsev, Nikita Kolosov, Oxana Rotar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioinformatics Advances|September 25, 2023
Detecting biased validation of predictive models in the positive-unlabeled setting: disease gene prioritization case studyIvan Molotkov, Mykyta Artomov
Disease Models & Mechanisms|December 16, 2024
Making sense of missense: challenges and opportunities in variant pathogenicity predictionIvan Molotkov, Elaine R Mardis, Mykyta Artomov
Nature Communications|December 13, 2025
Cost-effective non-additive GWAS across 2329 diseases in 500,349 individualsIvan Molotkov, Mitja Kurki, , et al.
JID Innovations : Skin Science From Molecules to Population Health|November 30, 2023
Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and VitiligoSarem Rashid, Ivan Molotkov, Nikolai Klebanov, et al.
Nature Communications|June 20, 2026
PGS Browser: a public platform for personalized polygenic score analysis and interpretationNikita Kolosov, Mary P Reeve, Pietro Della Briotta Parolo, et al.
Nature Communications|July 23, 2024
Complex trait susceptibilities and population diversity in a sample of 4,145 RussiansDmitrii Usoltsev, Nikita Kolosov, Oxana Rotar, et al.
Pageof 1